Vistaril

Product NDC
0069-5420
11-digit product format
000695420
Labeler code
0069
Product ID
0069-5420_1ef274bc-bb89-432e-b085-5d707ca372f3
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
hydroxyzine pamoate
Dosage form
CAPSULE
Route
ORAL
Labeler
Pfizer Laboratories Div Pfizer Inc
Application
NDA011459
Marketing category
NDA
Marketing start
1968-11-15
Marketing end
0000-00-00
Substance
HYDROXYZINE PAMOATE
Active strength
50 mg/1
Pharmacologic classes
Antihistamine [EPC], Histamine Receptor Antagonists [MoA]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct0069-5420DDiscontinued by firm2026-08-03
excluded packagepackage0069-54200069-5420-66DDiscontinued by firm2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage0069-5420-66d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage0069-5420-66f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage0069-5420-662ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage0069-5420-66a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage0069-5420-66cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage0069-5420-66cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage0069-5420-66302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage0069-5420-66ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage0069-5420-660efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage0069-5420-66ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage0069-5420-66367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage0069-5420-66557ba5c1ecfa…9c80585c8c6e…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N011459-002VISTARILHYDROXYZINE PAMOATEEQ 25MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 1982
N011459-004VISTARILHYDROXYZINE PAMOATEEQ 50MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 1982
N011459-006VISTARILHYDROXYZINE PAMOATEEQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
N011459-002AB
N011459-004AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N011459-002VISTARILEQ 25MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N011459-004VISTARILEQ 50MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N011459-006VISTARILEQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD, Approved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N011459-002VISTARILEQ 25MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N011459-004VISTARILEQ 50MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N011459-006VISTARILEQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD, Approved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08N011459-002VISTARILEQ 25MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N011459-004VISTARILEQ 50MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N011459-006VISTARILEQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD, Approved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N011459-002VISTARILEQ 25MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 1982fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N011459-004VISTARILEQ 50MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 1982fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N011459-006VISTARILEQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD, Approved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N011459-002VISTARILEQ 25MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 1982b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N011459-004VISTARILEQ 50MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 1982b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N011459-006VISTARILEQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD, Approved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N011459-002VISTARILEQ 25MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 198203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N011459-004VISTARILEQ 50MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 198203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N011459-006VISTARILEQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD, Approved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N011459-002VISTARILEQ 25MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 19822680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N011459-004VISTARILEQ 50MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 19822680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N011459-006VISTARILEQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD, Approved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N011459-002VISTARILEQ 25MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 19825bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N011459-004VISTARILEQ 50MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 19825bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N011459-006VISTARILEQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD, Approved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N011459-002VISTARILEQ 25MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 1982d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N011459-004VISTARILEQ 50MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 1982d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N011459-006VISTARILEQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD, Approved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N011459-002VISTARILEQ 25MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 1982d06236e962d9…
2024-10-29 15:01 UTC2024-10N011459-004VISTARILEQ 50MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 1982d06236e962d9…
2024-10-29 15:01 UTC2024-10N011459-006VISTARILEQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD, Approved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N011459-002VISTARILEQ 25MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 198279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N011459-004VISTARILEQ 50MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 198279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N011459-006VISTARILEQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD, Approved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N011459-002VISTARILEQ 25MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 1982301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N011459-004VISTARILEQ 50MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 1982301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N011459-006VISTARILEQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALApproved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N011459-002VISTARILEQ 25MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 19821e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N011459-004VISTARILEQ 50MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 19821e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N011459-006VISTARILEQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALApproved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05N011459-002VISTARILEQ 25MG HYDROCHLORIDECAPSULE / ORALABRLD, Approved before 19828072bd15b7f6…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 80 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02N011459-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N011459-004AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N011459-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N011459-004AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08N011459-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N011459-004AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N011459-002AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N011459-004AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N011459-002AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N011459-004AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N011459-002AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N011459-004AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N011459-002AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N011459-004AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N011459-002AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N011459-004AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N011459-002AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N011459-004AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N011459-002AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10N011459-004AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N011459-002AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N011459-004AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N011459-002AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N011459-004AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N011459-002AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N011459-004AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05N011459-002AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05N011459-004AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N011459-002AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N011459-004AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N011459-002AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N011459-004AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N011459-002AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N011459-004AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N011459-002AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12N011459-004AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N011459-002AB1bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N011459-004AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N011459-002AB1782e0a99824c…
2021-12-28 21:50 UTC2021-12N011459-004AB1782e0a99824c…

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0069-5420-66EA - Each0069-5420b67bbae7-f771-43eb-911f-e7b99ef0ee2212012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
HYDROXYZINE PAMOATEACTIVE INGREDIENTM20215MUFRVISTARIL (HYDROXYZINE PAMOATE) CAPSULE VISTARIL (HYDROXYZINE PAMOATE) SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC]8
HYDROXYZINEACTIVE MOIETY30S50YM8OGVISTARIL (HYDROXYZINE PAMOATE) CAPSULE VISTARIL (HYDROXYZINE PAMOATE) SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC]8
CARBOXYMETHYLCELLULOSE SODIUMINACTIVE INGREDIENTK679OBS311VISTARIL (HYDROXYZINE PAMOATE) CAPSULE VISTARIL (HYDROXYZINE PAMOATE) SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC]8
D&C RED NO. 33INACTIVE INGREDIENT9DBA0SBB0LVISTARIL (HYDROXYZINE PAMOATE) CAPSULE VISTARIL (HYDROXYZINE PAMOATE) SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC]8
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3GVISTARIL (HYDROXYZINE PAMOATE) CAPSULE VISTARIL (HYDROXYZINE PAMOATE) SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC]8
FD&C GREEN NO. 3INACTIVE INGREDIENT3P3ONR6O1SVISTARIL (HYDROXYZINE PAMOATE) CAPSULE VISTARIL (HYDROXYZINE PAMOATE) SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC]8
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A8VISTARIL (HYDROXYZINE PAMOATE) CAPSULE VISTARIL (HYDROXYZINE PAMOATE) SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC]8
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30VISTARIL (HYDROXYZINE PAMOATE) CAPSULE VISTARIL (HYDROXYZINE PAMOATE) SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC]8
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3VISTARIL (HYDROXYZINE PAMOATE) CAPSULE VISTARIL (HYDROXYZINE PAMOATE) SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC]8
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JVISTARIL (HYDROXYZINE PAMOATE) CAPSULE VISTARIL (HYDROXYZINE PAMOATE) SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC]8
SORBIC ACIDINACTIVE INGREDIENTX045WJ989BVISTARIL (HYDROXYZINE PAMOATE) CAPSULE VISTARIL (HYDROXYZINE PAMOATE) SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC]8
SORBITOLINACTIVE INGREDIENT506T60A25RVISTARIL (HYDROXYZINE PAMOATE) CAPSULE VISTARIL (HYDROXYZINE PAMOATE) SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC]8
SUCROSEINACTIVE INGREDIENTC151H8M554VISTARIL (HYDROXYZINE PAMOATE) CAPSULE VISTARIL (HYDROXYZINE PAMOATE) SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC]8
WATERINACTIVE INGREDIENT059QF0KO0RVISTARIL (HYDROXYZINE PAMOATE) CAPSULE VISTARIL (HYDROXYZINE PAMOATE) SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC]8

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0069-5420VISTARIL (HYDROXYZINE PAMOATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]19Legacy NDC20240918_c271f97f-040e-492b-9194-2c8b74675a95.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0069-5420-6600069542066100 CAPSULE in 1 BOTTLE (0069-5420-66) 100 capsule1968-11-150000-00-00NoNoCurrent